Risk of Guillain-Barre syndrome after COVID-19 vaccination or SARS-CoV-2 infection: A multinational self-controlled case series study. Nasreen S, Jiang Y, Lu H, Lee A, et al. Vaccine 2025;60:127291.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Nasreen S, Jiang Y, Lu H, Lee A, et al. Risk of Guillain-Barre syndrome after COVID-19 vaccination or SARS-CoV-2 infection: A multinational self-controlled case series study. Vaccine 2025;60:127291.
PMID: 40440921